Summary & Overview
CPT 81509: Laboratory Algorithmic Risk Assessment for PAPP–A, hCG, DIA
CPT code 81509 represents a laboratory-based algorithmic risk assessment that measures three proteins — PAPP–A, hCG, and DIA — and combines those assay results with patient data to produce a reported patient risk score. This code captures both the technical testing for those analytes and the computational analysis required to generate a quantitative risk estimate. Its use matters nationally as algorithm-driven laboratory diagnostics are increasingly integrated into prenatal screening and other risk-assessment pathways, influencing clinical decision-making and coverage discussions.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise summary of coverage considerations, common modifier usage, and clinical context for how the test is performed and reported. The publication highlights benchmarking points relevant to payers and providers, describes the clinical workflow and typical laboratory site of service, and outlines policy and coding elements that affect billing and claims processing. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 81509 describes a laboratory service in which the lab analyst performs technical testing for three proteins — PAPP–A, hCG, and DIA — and applies an algorithmic analysis combining patient data and lab results to generate and report a patient risk score.
Service type: Laboratory algorithmic risk assessment
Typical site of service: Clinical laboratory or hospital laboratory (laboratory-based testing with associated analytic reporting)
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A pregnant patient between 9 and 14 weeks' gestation presents for first‑trimester aneuploidy screening. The obstetrician orders a maternal serum screen that includes measurement of pregnancy‑associated plasma protein A (PAPP‑A), free beta‑human chorionic gonadotropin (hCG), and cell‑free DNA or a Dia protein panel (DIA) as part of a combined biochemical and algorithmic risk assessment. A phlebotomy technician collects a serum specimen at an outpatient OB clinic or women's health lab. The specimen is sent to a certified clinical laboratory where a laboratory analyst performs the technical assays for the three proteins and enters patient demographic and gestational age data into a validated proprietary algorithm. The lab generates a patient‑specific risk score for common aneuploidies and reports results electronically to the ordering provider. Typical site of service is an outpatient hospital laboratory, independent diagnostic testing facility, or hospital-based pathology lab. Common clinical workflow steps include order placement by the obstetric provider, specimen collection, sample accessioning and analysis in the lab, algorithmic computation of risk, and issuance of a final report to the ordering clinician for counseling and follow‑up testing decisions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (standard) | Use when no special circumstances apply to the lab's billing or service delivery. |